Estrace (Estradiol Vaginal) - Adverse Event Reports - Disability

Intervertebral Disc Protrusion (1),  Ventricular Extrasystoles (1),  Nausea (1),  Nipple Pain (1),  Breast Cancer in Situ (1),  Emotional Distress (1),  Rhinitis Allergic (1),  Palpitations (1),  Chest Pain (1),  Scar (1)

Adverse event in female receiving Estrace (Estradiol Vaginal)

Reported by a individual with unspecified qualification from United States on 2007-03-08

Patient: female

Adverse reactions / side effects: Nipple Pain, Breast Cancer in Situ, Electrocardiogram Ambulatory Abnormal, Mammogram Abnormal, Laboratory Test Abnormal, Palpitations, Uterine Leiomyoma, Chest Pain, Injury, Ventricular Extrasystoles, Intervertebral Disc Protrusion, Nausea, Supraventricular Extrasystoles, Arrhythmia, Emotional Distress, Anxiety, Rhinitis Allergic, Syncope, Presyncope, Scar

Adverse event resulted in: disablity

Suspect drug(s):
Climara ^schering^
    Dosage: 0.1 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1997-07-01

Estrace
    Dosage: 1 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1997-06-27

Premarin
    Dosage: 0.062 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1996-03-08

Vivelle
    Dosage: 0.05 mg/day, unk
    Indication: Hormone Replacement Therapy
    Start date: 1996-06-20